Table 1.

Main clinical characteristics of 7 previously reported patients with ruxolitinib withdrawal syndrome, including this case report

No	Sex, Age	Disease	Clinical characteristics of RWS
0	M, 76	PMF	Recurrent fever, biological inflammatory syndrome and ARDS
1 [17]	F, 59	Post-PV MF	Respiratory distress, severe anemia requiring transfusion and symptomatic splenomegalia
2 [17]	F, 69	Post-PV MF	Respiratory distress with septic shock-like syndrome
3 [17]	M, 44	Post-PV MF	Respiratory distress associated with pleural and pericardial effusion
4 [17]	M, 64	PMF	Recurrent fever and recurrence of PMF symptoms (fatigue, pruritus, night sweats, splenomegalia with splenic infarction)
5 [17]	F, 56	Post-PV MF	Disseminated intravascular coagulation-like syndrome
6 [18]	F, 70	Post-PV MF	Recurrent fever, dyspnea, diarrhea and accelerated splenomegalia

F female, M male, MF primary myelofibrosis, post-PV MF post polycythemia vera myelofibrosis, RWS ruxolibinib withdrawal syndrome, PMF primary myelofibrosis, ARDS acute respiratory distress syndrome